Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine

Author:

Zhou Yitian1ORCID,Arribas Gabriel Herras1ORCID,Turku Ainoleena12ORCID,Jürgenson Tuuli3,Mkrtchian Souren1ORCID,Krebs Kristi34ORCID,Wang Yi5ORCID,Svobodova Barbora6ORCID,Milani Lili3ORCID,Schulte Gunnar1ORCID,Korabecny Jan6ORCID,Gastaldello Stefano1ORCID,Lauschke Volker M.17ORCID

Affiliation:

1. Department of Physiology and Pharmacology, Karolinska Institutet, 171 77 Stockholm, Sweden.

2. Orion Pharma R&D, P.O. Box 65 (Orionintie 1), FI-02101 Espoo, Finland.

3. Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia.

4. Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.

5. Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, 310058 Hangzhou, China.

6. Biomedical Research Centre, University Hospital Hradec Králové, Sokolská 581, 500 05 Hradec Králové, Czech Republic.

7. Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.

Abstract

Rare genetic variants in human drug targets affect drug efficacy and can guide personalized drug selection and drug development.

Publisher

American Association for the Advancement of Science (AAAS)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.7亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3